AngioDynamics, Inc.

NASDAQ:ANGO

Medical - Instruments & Supplies

Healthcare
$11.32 +1.71%

+$0.20 today

Market cap
$476.06M
Beta
0.36
P/E (TTM)
-15.8
EPS (TTM)
-$0.75
52W Low $8.36High $13.99

Volume 0.32M

Average 0.40M

ANGO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

AngioDynamics, Inc.NASDAQ: ANGO

Weighted Avg Shares · Q3 FY2026 · quarter ended Feb 2026

Weighted avg shares grows in line with its trailing trend

Q3 FY2026 weighted avg shares of 41.6M shares rose 1.8% year over year, in line with the +1.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +1.7% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.8% holds above the trailing-twelve-month pace of +1.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
41.6M+0.5% QoQ
Last fiscal yearMay 2025
40.98M+2.0% YoY
LTMFeb 2026
41.29M+1.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.8%——
1 year+2.0%——
3-year CAGR+1.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
40.98M USD
Year-over-year change
+2.0%
4-year CAGR
+1.7%

Weighted Avg Shares vs competitors

How ANGO compares with its peers on the latest reported figures

  • ANGO's LTM Feb 2026 weighted avg shares of 41.29M shares is the 6th highest of the 9 companies compared; the peer median is 51.83M shares.
  • Its year-over-year change of +1.4% is the 2nd highest of 9, against a peer median of +0.2%.
  • Over three fiscal years its annual growth of +1.7% compares with a peer median of +1.0%.
ANGO Competitors Peer median
Weighted Avg Shares for ANGO and competitors
Company Period LTM YoY 3-year CAGR
BSXBoston Scientific CorporationLTM Jun 20261.48B +0.4%+1.1%
BDXBecton, Dickinson and CompanyLTM Sep 2026278.36M -3.4%-0.9%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202676.73M -0.1%-2.6%
MMSIMerit Medical Systems, Inc.LTM Sep 202659.58M +1.1%+1.4%
TFXTeleflex IncorporatedLTM Jun 202644.07M -4.5%-1.6%
ANGOAngioDynamics, Inc.LTM Feb 202641.29M +1.4%+1.7%
PENPenumbra, Inc.LTM Jun 202639.21M +1.4%+0.9%
CNMDCONMED CorporationLTM Mar 202630.87M -0.0%+1.1%
LMATLeMaitre Vascular, Inc.LTM Mar 202622.7M +0.9%+1.0%
Peer median (excluding ANGO) 51.83M+0.2%+1.0%

Competitors are the stored peer set for ANGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue291.01M316.22M338.75M303.91M292.5M
Cost of Revenue134.22M150.49M164.51M149.22M134.79M
Gross Profit156.79M165.73M174.25M154.7M157.71M
Gross Margin53.9%52.4%51.4%50.9%53.9%
Research & Development36.39M30.74M29.88M31.51M26.22M
Selling, General & Admin117.22M133.75M144.25M143.98M145.23M
Operating Expenses192.07M194.2M225.43M347.13M197.66M
Depreciation & Amortization25.92M29.35M30.87M27.71M25.8M
EBITDA(9.28M)11.13M12.19M(6.13M)1.74M
EBITDA Margin-3.2%3.5%3.6%-2.0%0.6%
Operating Income(35.28M)(28.47M)(51.18M)(192.44M)(39.95M)
Operating Margin-12.1%-9.0%-15.1%-63.3%-13.7%
Interest Income0001.61M978K
Interest Expense861K688K2.7M00
Other Income / Expenses(769K)(1.48M)(3.26M)797K5.92M
Income Before Tax(36.05M)(29.95M)(54.44M)(191.64M)(34.03M)
Pre-Tax Margin-12.4%-9.5%-16.1%-63.1%-11.6%
Income Tax Expense(4.5M)(3.4M)(2M)(7.29M)(39K)
Net Income(31.55M)(26.55M)(52.44M)(184.35M)(33.99M)
Net Margin-10.8%-8.4%-15.5%-60.7%-11.6%
EPS (Basic)(0.82)(0.68)(1.33)(4.59)(0.83)
EPS (Diluted)(0.82)(0.68)(1.33)(4.59)(0.83)
Weighted Avg Shares38.34M39.01M39.48M40.18M40.98M
Weighted Avg Shares (Diluted)38.34M39.01M39.48M40.18M40.98M

AngioDynamics, Inc.

NASDAQ:ANGO

Intrinsic Alpha fair value

Locked

Current Price

$11.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.